5.4. Analysis.
Comparison 5 Rivastigmine 5 cm2 patch (4.6 mg/day) versus placebo, Outcome 4 Disability Assessment for Dementia (DAD) (change from baseline at 24 weeks) ITT.
Comparison 5 Rivastigmine 5 cm2 patch (4.6 mg/day) versus placebo, Outcome 4 Disability Assessment for Dementia (DAD) (change from baseline at 24 weeks) ITT.